Schering-Plough to buy Akzo's Organon for $14.4 bln
457209
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough  for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.
119312
Akzo Nobel said on Monday it was selling its pharmaceuticals unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offer.
691450
BERLIN -- German chemical and drug maker Bayer AG and New Jersey pharmaceutical company Schering-Plough Corp. announced Monday they have entered a strategic alliance under which Schering-Plough will distribute
238458
Seeking to improve its drug discovery technology and establish a beachhead in the fertile Cambridge biotechnology cluster, drug giant Schering-Plough Corp. of Kenilworth, N.J., said it would buy NeoGenesis Pharmaceuticals Inc. of Cambridge for an undisclosed sum.
287707
Serono SA , one of the world's largest biotechnology companies, was bought yesterday by German chemical giant Merck KGaA in a deal worth more than $13 billion.
40841
Swedish-Dutch chemicals and paints group Akzo Nobel's announced Wednesday that it had completed the purchase of British peer ICI.
336979
Drugs firm Akzo Nobel will sell its drugs unit Organon BioSciences to Schering-Plough for 11bn euros.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
24676
Bayer AG forged an alliance for its struggling pharmaceuticals business with US drugmaker Schering-Plough on Monday, cutting costs and marking another step in the German company&#39;s transformation.
633530
Schering-Plough Corp.  is  seriously considering approaching Bristol-Myers Squibb Co.   about a possible merger, according to a report in The  Star-Ledger newspaper on Friday.
145826
American Oriental Bioengineering makes an acquisition.
541389
BOSTON, Aug. 29 -- Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.
269171
Merck of Germany announced it would take control of Serono, a Swiss pharmaceutical maker, for 10.6 billion euros ($13.5 billion).
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
624821
NEW YORK -- Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.
150005
Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.
265877
FRANKFURT/ZURICH  - German drugmaker Merck KGaA   MRCG.DE unveiled a surprise 16.6-billion-Swiss franc ($13.3   billion) deal to buy Swiss biotech firm Serono on Thursday,   creating a new force in European pharmaceuticals.